Managing high-risk S8, S4B and S4D medicines
November 3, 2022
PDL NSW members were recently sent a Forum communique on 13 October 2022 regarding the joint initiative between the Pharmacy Council of NSW, NSW Health
PDL NSW members were recently sent a Forum communique on 13 October 2022 regarding the joint initiative between the Pharmacy Council of NSW, NSW Health
The Pharmacy Council of NSW has launched a new initiative involving a quarterly forum bringing together key pharmacy stakeholder agencies to discuss issues of relevance
Pharmacists practising in Queensland are advised the UTIPP-Q pilot has finished and the Urinary Tract Infection Community Pharmacy Service is now allowed under the Pharmacists
PDL continues to see notifications involving forged prescriptions and would like to remind pharmacists of the need to be vigilant when assessing the validity of
Pharmacists practising in Queensland are advised that after Friday, 9 September 2022, new pharmacists and pharmacies will no longer be accepted into the UTIPP-Q pilot.
PDL has recently received several incident reports where the incorrect varicella vaccine has been prescribed and/or supplied. Prescribing software programs have variations on how the
It is no surprise that the top four drugs on our list are Schedule 8’s (S8s). Dispensing errors can happen with any drug but the
Schedule 8 medicines, in particular opioids, are often involved in notifications to PDL. An Australian Institute of Health and Welfare report on opioid harm in
PDL is pleased to provide further information to pharmacists practising in Queensland about the UTIPP-Q pilot program and recent announcements. The following advice is directed
Lapsed Professional Indemnity insurance arrangements – Section 130(3)(a)(iii), National Law In busy working life, the renewal of professional indemnity insurance can easily be missed. Common